These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34706040)

  • 1. Health Technology Assessment: informed by science or in the service of politics?
    Soárez PC
    Rev Saude Publica; 2021; 55():64. PubMed ID: 34706040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment in four countries: response from political science.
    Chinitz D
    Int J Technol Assess Health Care; 2004; 20(1):55-60. PubMed ID: 15176177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Social Science Literature on Health Technology Assessment: A Narrative Review.
    Löblová O; Trayanov T; Csanádi M; Ozierański P
    Value Health; 2020 Jan; 23(1):3-9. PubMed ID: 31952670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'The problem is small enough, the problem is big enough': a qualitative study of health technology assessment and public policy on drug funding decisions for children.
    Denburg AE; Giacomini M; Ungar WJ; Abelson J
    Int J Equity Health; 2020 Mar; 19(1):45. PubMed ID: 32228588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology assessment and the sociopolitics of health technologies.
    Lehoux P; Blume S
    J Health Polit Policy Law; 2000 Dec; 25(6):1083-120. PubMed ID: 11142053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigms in operation: explaining pharmaceutical benefit assessment outcomes in England and Germany.
    Kieslich K
    Health Econ Policy Law; 2020 Jul; 15(3):370-385. PubMed ID: 30975237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: evaluation in analytic theory and political practice.
    Brown LD; Gusmano MK
    J Health Polit Policy Law; 2013 Dec; 38(6):1071-9. PubMed ID: 23974474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.
    Swami S; Srivastava T
    Value Health; 2020 Jan; 23(1):39-42. PubMed ID: 31952672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology adoption and the politics of governance in the UK.
    Milewa T
    Soc Sci Med; 2006 Dec; 63(12):3102-12. PubMed ID: 16982120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?
    Ciani O; Tarricone R; Torbica A
    Health Policy; 2012 Dec; 108(2-3):194-202. PubMed ID: 23093020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy initiation and political levers in health policy: lessons from Ghana's health insurance.
    Seddoh A; Akor SA
    BMC Public Health; 2012; 12 Suppl 1(Suppl 1):S10. PubMed ID: 22992292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The politics of EPSDT policy in the 1990s: policy entrepreneurs, political streams, and children's health benefits.
    Sardell A; Johnson K
    Milbank Q; 1998; 76(2):175-205. PubMed ID: 9614420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putting newborn hearing screening on the political agenda in Belgium: local initiatives toward a community programme - a qualitative study.
    Vos B; Lagasse R; Levêque A
    Health Res Policy Syst; 2014 Jul; 12():32. PubMed ID: 24986647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of the impact of the NHS Health Technology Assessment Programme.
    Hanney S; Buxton M; Green C; Coulson D; Raftery J
    Health Technol Assess; 2007 Dec; 11(53):iii-iv, ix-xi, 1-180. PubMed ID: 18031652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilising modern facts: health technology assessment and the politics of evidence.
    May C
    Sociol Health Illn; 2006 Jul; 28(5):513-32. PubMed ID: 16910945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seventy years of the British National Health Service: problem, politics and policy streams.
    Powell M
    Health Econ Policy Law; 2019 Jan; 14(1):29-39. PubMed ID: 29655400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regulatory governance perspective on health technology assessment (HTA) in France: the contextual mediation of common functional pressures.
    Barron AJ; Klinger C; Shah SM; Wright JS
    Health Policy; 2015 Feb; 119(2):137-46. PubMed ID: 25458970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India.
    Dabak SV; Pilasant S; Mehndiratta A; Downey LE; Cluzeau F; Chalkidou K; Luz ACG; Youngkong S; Teerawattananon Y
    Health Res Policy Syst; 2018 Nov; 16(1):115. PubMed ID: 30486827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMERGENCE OF "DRIVERS" FOR THE IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT.
    Castro Jaramillo HE; Moreno-Mattar O; Osorio-Cuevas D
    Int J Technol Assess Health Care; 2016 Jan; 32(4):300-306. PubMed ID: 27691993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.